Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BY 4.0Frontiers in Neurology

Development and internal validation of CTA-based radiomics models for differentiating symptomatic from asymptomatic unruptured spontaneous intracranial vertebrobasilar artery dissection

  1. 1Department of Neurosurgery, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University

Abstract

Background: Spontaneous intracranial vertebrobasilar artery dissection (sIVBD) has heterogeneous clinical presentations, and conventional clinical and morphologic assessment may not fully characterize lesion heterogeneity. We aimed to develop and internally validate CTA-based radiomics models for differentiating symptomatic from asymptomatic unruptured sIVBD and to evaluate the incremental contribution of radiomics beyond conventional clinical and CTA features.

Methods: This retrospective single-center study included 173 patients with unruptured sIVBD, comprising 56 symptomatic and 117 asymptomatic patients. Patients were stratified into a development cohort ( n = 138) and an independent internal validation cohort ( n = 35). Radiomic features were extracted from subtraction CTA images after three-dimensional lesion segmentation. Feature reproducibility was assessed using inter-reader intraclass correlation coefficients. Four models were developed: a conventional CTA model (M1), a clinical plus conventional CTA model (M2), a radiomics XGBoost model (M3), and a combined model integrating M2 predictors with a cross-fitted radiomics probability (M4). Primary development-cohort evaluation used five-times-repeated five-fold stratified nested cross-validation. Discrimination, calibration, Brier score, and decision-curve analysis were assessed.

Results: Of 851 radiomic features, 722 (84.8%) met the prespecified reproducibility criterion. In patient-averaged out-of-fold evaluation, AUCs were 0.630 for M1, 0.681 for M2, 0.676 for M3, and 0.723 for M4. Compared with M2, M4 increased AUC by 0.0416 (95% CI, −0.0130 to 0.0962; p = 0.136) and reduced the Brier score by 0.0101 (95% bootstrap CI, −0.0208 to 0.0006). Across 25 outer folds, M4 had the highest mean AUC (0.715) and the lowest between-fold variability. In the independent internal validation cohort, AUCs were 0.814, 0.807, 0.803, and 0.966 for M1 through M4, respectively.

Conclusion: A combined model integrating clinical variables, conventional CTA features, and cross-fitted radiomics information showed the best overall performance for differentiating symptomatic from asymptomatic unruptured sIVBD. Radiomics may provide complementary quantitative information beyond conventional assessment.

Related

  1. Comparable Norovirus Shedding in Symptomatic and Asymptomatic Individuals: A Hospital-Based Study in Bangladesh
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Asymptomatic and symptomatic recurrence of TB among cured pulmonary TB patients
    M. Paradkar, S. Gaikwad, C. Padmapriyadarsini +17
    IJTLD openPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Clinical Characteristics and In-Hospital Course of Symptomatic Intracranial Hemorrhage After Intravenous Alteplase in Older Adults with Acute Ischemic Stroke: A Retrospective Cohort Study
    Sorina Nicoleta Munteanu, Dana Tutunaru, Aurel Nechita +7
    Neurology internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. The clinical application of a low-profile stent for symptomatic intracranial atherosclerotic stenosis in the middle cerebral artery: a retrospective study of the Atlas stent
    Wenyan Xu, Xu Guan, Fangfang Guo +13
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  5. Clinical Outcomes of Endoscopic Treatment for Asymptomatic and Symptomatic Common Bile Duct Stones: Incidence and Risk Factors for Post-ERCP Pancreatitis
    Jun-Ichi Hanatani, Koh Kitagawa, Shohei Asada +15
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref
BibTeX
@article{jiang2026development,
  title = {{Development and internal validation of CTA-based radiomics models for differentiating symptomatic from asymptomatic unruptured spontaneous intracranial vertebrobasilar artery dissection}},
  author = {Jia Jiang and Sheng Bi and Siming Gui and Lu Zheng and Youxiang Li and Qinglin Liu},
  journal = {Frontiers in Neurology},
  year = {2026},
  month = oct,
  doi = {10.3389/fneur.2026.1883223},
  url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1883223/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Development and internal validation of CTA-based radiomics models for differentiating symptomatic from asymptomatic unruptured spontaneous intracranial vertebrobasilar artery dissection
AU  - Jia Jiang
AU  - Sheng Bi
AU  - Siming Gui
AU  - Lu Zheng
AU  - Youxiang Li
AU  - Qinglin Liu
PY  - 2026
DA  - 2026/10/23
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2026.1883223
UR  - https://www.frontiersin.org/articles/10.3389/fneur.2026.1883223/full
AB  - Background: Spontaneous intracranial vertebrobasilar artery dissection (sIVBD) has heterogeneous clinical presentations, and conventional clinical and morphologic assessment may not fully characterize lesion heterogeneity. We aimed to develop and internally validate CTA-based radiomics models for differentiating symptomatic from asymptomatic unruptured sIVBD and to evaluate the incremental contribution of radiomics beyond conventional clinical and CTA features.  Methods: This retrospective single-center study included 173 patients with unruptured sIVBD, comprising 56 symptomatic and 117 asymptomatic patients. Patients were stratified into a development cohort ( n = 138) and an independent internal validation cohort ( n = 35). Radiomic features were extracted from subtraction CTA images after three-dimensional lesion segmentation. Feature reproducibility was assessed using inter-reader intraclass correlation coefficients. Four models were developed: a conventional CTA model (M1), a clinical plus conventional CTA model (M2), a radiomics XGBoost model (M3), and a combined model integrating M2 predictors with a cross-fitted radiomics probability (M4). Primary development-cohort evaluation used five-times-repeated five-fold stratified nested cross-validation. Discrimination, calibration, Brier score, and decision-curve analysis were assessed.  Results: Of 851 radiomic features, 722 (84.8%) met the prespecified reproducibility criterion. In patient-averaged out-of-fold evaluation, AUCs were 0.630 for M1, 0.681 for M2, 0.676 for M3, and 0.723 for M4. Compared with M2, M4 increased AUC by 0.0416 (95% CI, −0.0130 to 0.0962; p = 0.136) and reduced the Brier score by 0.0101 (95% bootstrap CI, −0.0208 to 0.0006). Across 25 outer folds, M4 had the highest mean AUC (0.715) and the lowest between-fold variability. In the independent internal validation cohort, AUCs were 0.814, 0.807, 0.803, and 0.966 for M1 through M4, respectively.  Conclusion: A combined model integrating clinical variables, conventional CTA features, and cross-fitted radiomics information showed the best overall performance for differentiating symptomatic from asymptomatic unruptured sIVBD. Radiomics may provide complementary quantitative information beyond conventional assessment.
SN  - 1664-2295
ER  -